I am receiving Ocrevus infusions at a local MS Infusion Center affiliated with a reputable hospital. In addition to the cost of the infusion, the Center is billing my insurance company 375% of the retail cost of the drug. In an attempt to control costs, my company has directed my pharmaceutical insurance to supply the drug for infusion, presumably at a much lower rate. However, there is no infusion center within 50 miles that will accept Ocrevus from a 3rd party pharmacy. I am concerned that Ocrevus is going to be priced out of reach and withdrawn from the formulary.